Sleep Apnea Treatment During Cardiac Rehabilitation of Congestive Heart Failure Patients
NCT ID: NCT01120548
Last Updated: 2015-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2010-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Cardiac Rehabilitation Program in Patients With Heart Failure
NCT04245813
Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes Respiration
NCT01212705
Value of Cardiac Rehabilitation on the Treatment of Cardiovascular Disease
NCT05320848
Heart Failure and Sleep Apnea: Exercise Training and Continuous Positive Airway Pressure
NCT01538069
Cardiac Rehabilitation in Patients With Continuous Flow Left Ventricular Assist Devices:Rehab VAD Trial
NCT01584895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The cardiac rehabilitation programme will include education, secondary prevention and physical training components in each of the two groups. The physical training component will include a minimal "base" of activities that is identical for both groups. The nocturnal therapy device will be adapted to the type of SDB specific to each patient (central, mixed, obstructive). The randomisation will be stratified by centre according to predictive factors for performance improvement during rehabilitation.
The main objective is to evaluate the improvement in physical performance resulting from adapted ventilation on SDB compared to physical training alone in patients with heart failure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rehabilitation + Ventilation Group
Patient Heart Failure with sleep disordered breathing who follows ventilation therapy and physical training.
ventilation therapy
The service provider will provide the patient with the ventilation device and will explain to the patient how to operate the device and how to fit the mask according to the specifications.
There will be an oximetry recording during ventilation on the first night. After the first night, the ventilation parameters recorded by the machine and the oximetry results will be read and used to adjust the settings.
Starting the first week and at the end of the programme, the following ventilation parameters will be collected: compliance, leaks, AHI, ventilation mode, pressures used. The threshold of length of nocturnal ventilation fixed to 3h per night on average in order to consider a compliant patient.
Rehabilitation Only Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ventilation therapy
The service provider will provide the patient with the ventilation device and will explain to the patient how to operate the device and how to fit the mask according to the specifications.
There will be an oximetry recording during ventilation on the first night. After the first night, the ventilation parameters recorded by the machine and the oximetry results will be read and used to adjust the settings.
Starting the first week and at the end of the programme, the following ventilation parameters will be collected: compliance, leaks, AHI, ventilation mode, pressures used. The threshold of length of nocturnal ventilation fixed to 3h per night on average in order to consider a compliant patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred to cardiac rehabilitation
* With an EF \< 40%
* And an apnea-hypopnea index \> 15/h (determined by a nasal flow recording method)
* Have signed the consent document to participate in the study.
Exclusion Criteria
* Patients who already use sleep disordered breathing devices
* Resting SBP \< 80 mmHg (averaged over 3 separate measurements)
* Recent angioplasty (within the last 10 days)
* Infarction within the last 10 days
* Heart surgery within the last 15 days
* Valve dysfunction requiring surgery
* Uncontrolled high blood pressure (BP \> 180 and/or 110 mmHg)
* Anaemia (Hb \< 9g/dl)
* Haemodialysis
* Patient receiving circulatory assistance
* Severe chronic respiratory failure (FEV1 \< 1000) or hypercapnia greater than 46 mmHg
* Patient incapable of performing a 6 minute walk test and an exercise test
* Absolute contraindication for an exercise test and/or physical training according to the recommendations of the French Society of Cardiology
* Evolving myopericarditis
* Severe ventricular rhythm disorders that do not stabilise with treatment
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ResMed
INDUSTRY
ResMed Foundation
OTHER
Adep Assistance
OTHER
French Cardiology Society
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sonia Corone, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Médical de Bligny
Marie-Christine Iliou, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Corentin Celton
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Médical de Bligny
Briis-sous-Forges, , France
Clinique de Châtillon
Châtillon, , France
Hôpital Albert Chenevier
Créteil, , France
Dieulefit Santé
Dieulefit, , France
Hôpital Arthur Gardiner
Dinard, , France
Clinique de cardiopneumologie
Durtol, , France
Hôpital Sud - Institut de Rééducation
Échirolles, , France
Hôpital Corentin Celton
Issy-les-Moulineaux, , France
Clinique de La Mitterie
Lomme, , France
Centre IRIS
Marcy-l'Étoile, , France
Centre Cardio-Vasculaire Valmante
Marseille, , France
Clinique de réadaptation cardiaque Cardiocéan
Puilboreau, , France
Hôpital Nord 6
Saint-Etienne, , France
Hôpital Intercommunal Sud Léman Valserine
Saint-Julien-en-Genevois, , France
Centre William Harvey - le Haut Boscq
Saint-Martin-d'Aubigny, , France
Centre de réadaptation cardiaque Leopold Bellan
Tracy-le-Mont, , France
Institut Régional de Réadaptation
Vandœuvre-lès-Nancy, , France
La Maison du Mineur
Vence, , France
Centre Hospitalier Calmette
Yerres, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.